Macrophage- and neutrophil- dominant arthritis in human IL-1α transgenic mice

To study the effects of IL-1α in arthritis, we generated human IL-1α (hIL-1α). Transgenic mice expressed hIL-1α mRNA in various organs, had high serum levels of hIL-1α, and developed a severe polyarthritic phenotype at 4 weeks of age. Not only bone marrow cells but also synoviocytes from knee joints produced biologically active hIL-1α. Synovitis started 2 weeks after birth, and 8-week-old mice showed hyperplasia of the synovial lining layer, the formation of hyperplastic synovium (pannus) and, ultimately, destruction of cartilage. Hyperplasia of the synovial lining was due to the accumulation of macrophage-like cells expressing F4/80 molecules. hIL-1α was widely distributed in macrophage- and fibroblast-like cells of the synovial lining cells, as well as synovial fluid monocytes. T and B cells were rare in the synovial fluid, and analysis of marker expression suggests that synoviocytes were directly histolytic and did not act as antigen-presenting cells. In the joints of these mice, we found elevated levels of cells of the monocyte/macrophage and granulocyte lineages and of polymorphonuclear neutrophils (PMNs), most of which expressed Gr-1, indicating that they were mature, tissue-degrading PMNs. Cultured synoviocytes and PMNs from these animals overexpress GM-CSF, suggesting that the hematopoietic changes induced by IL-1 and the consequent PMN activation and joint destruction are mediated by this cytokine.

[1]  L. Joosten,et al.  IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation. , 1999, Journal of immunology.

[2]  G. Kollias,et al.  Mice lacking mature T and B lymphocytes develop arthritic lesions after immunization with type II collagen. , 1999, Journal of immunology.

[3]  O. Majdic,et al.  Initiation of the autologous mixed lymphocyte reaction requires the expression of costimulatory molecules B7-1 and B7-2 on human peripheral blood dendritic cells. , 1998, Journal of immunology.

[4]  G. Kollias,et al.  DBA/1 mice expressing the human TNF-alpha transgene develop a severe, erosive arthritis: characterization of the cytokine cascade and cellular composition. , 1997, Journal of immunology.

[5]  D. Livingston,et al.  INTERLEUKIN-1β CONVERTING ENZYME INHIBITION BLOCKS PROGRESSION OF TYPE II COLLAGEN-INDUCED ARTHRITIS IN MICE , 1996 .

[6]  L. Joosten,et al.  Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: a comparative study using anti-TNFalpha, anti-IL-1alpha/beta and IL-1Ra. , 1996 .

[7]  J. Kieffer,et al.  Inflammatory skin disease in transgenic mice that express high levels of interleukin 1 alpha in basal epidermis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[8]  W. B. van den Berg,et al.  Major role for interleukin 1 but not for tumor necrosis factor in early cartilage damage in immune complex arthritis in mice. , 1995, The Journal of rheumatology.

[9]  G. Kollias,et al.  The type I interleukin‐1 receptor acts in series with tumor necrosis factor (TNF) to induce arthritis in TNF‐transgenic mice , 1995, European journal of immunology.

[10]  M. Furue,et al.  Selective regulation of ICAM‐1 and major histocompatibility complex class I and II molecule expression on epidermal Langerhans cells by some of the cytokines released by keratinocytes and T cells , 1994, European journal of immunology.

[11]  P. Wooley,et al.  The effect of an interleukin-1 receptor antagonist protein on type II collagen-induced arthritis and antigen-induced arthritis in mice. , 1993, Arthritis and rheumatism.

[12]  R. Locksley,et al.  The 31-kDa precursor of interleukin 1 alpha is myristoylated on specific lysines within the 16-kDa N-terminal propiece. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[13]  K. Lövgren,et al.  The induction of cell‐associated and secreted IL‐1 by iscoms, matrix or micelles in murine splenic cells , 1993, Clinical and experimental immunology.

[14]  N. Miyasaka,et al.  Detection of myeloid precursors (granulocyte/macrophage colony forming units) in the bone marrow adjacent to rheumatoid arthritis joints. , 1992, The Journal of rheumatology.

[15]  M. Feldmann,et al.  Detection of cytokines at the cartilage/pannus junction in patients with rheumatoid arthritis: implications for the role of cytokines in cartilage destruction and repair. , 1992, British journal of rheumatology.

[16]  P. Linsley,et al.  Functional expression of the costimulatory molecule, B7/BB1, on murine dendritic cell populations , 1992, The Journal of experimental medicine.

[17]  M. Elliott,et al.  The excess numbers of peritoneal macrophages in granulocyte-macrophage colony-stimulating factor transgenic mice are generated by local proliferation , 1992, The Journal of experimental medicine.

[18]  S. Yoshino,et al.  Depletion of alpha/beta T cells by a monoclonal antibody against the alpha/beta T cell receptor suppresses established adjuvant arthritis, but not established collagen-induced arthritis in rats , 1992, The Journal of experimental medicine.

[19]  H. Spits,et al.  IL-1, IL-4, and IFN-gamma differentially regulate cytokine production and cell surface molecule expression in cultured human thymic epithelial cells. , 1991, Journal of immunology.

[20]  D. Kioussis,et al.  Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. , 1991, The EMBO journal.

[21]  D. Longo,et al.  Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells. , 1991, Journal of immunology.

[22]  P. Ghezzi,et al.  Interleukin-1 induces tumor necrosis factor (TNF) in human peripheral blood mononuclear cells in vitro and a circulating TNF-like activity in rabbits. , 1990, The Journal of infectious diseases.

[23]  W. V. D. Berg,et al.  Effects of murine recombinant interleukin 1 on synovial joints in mice: measurement of patellar cartilage metabolism and joint inflammation. , 1990, Annals of the rheumatic diseases.

[24]  D. Longo,et al.  Interleukin-1 enhances survival of lethally irradiated mice treated with allogeneic bone marrow cells , 1989 .

[25]  G. Bagby Interleukin-1 and hematopoiesis. , 1989, Blood reviews.

[26]  S. Durum,et al.  Membrane IL-1: IL-1 alpha precursor binds to the plasma membrane via a lectin-like interaction. , 1989, Journal of immunology.

[27]  M. Moore,et al.  Effects of interleukin-1 on hematopoietic progenitors: evidence of stimulatory and inhibitory activities in a primate model. , 1989, Blood.

[28]  L. Butler,et al.  The progression of the inflammation in established collagen‐induced arthritis can be altered by treatments with immunological or pharmacological agents which inhibit T cell activities , 1988, European journal of immunology.

[29]  H. Colten,et al.  The precursor of interleukin-1 alpha is phosphorylated at residue serine 90. , 1988, The Journal of biological chemistry.

[30]  R. Jonsson,et al.  Early appearance of activated CD4+ T lymphocytes and class II antigen-expressing cells in joints of DBA/1 mice immunized with type II collagen. , 1988, Laboratory investigation; a journal of technical methods and pathology.

[31]  B Henderson,et al.  Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[32]  C. Dinarello,et al.  Human recombinant interleukin 1 stimulates collagenase and prostaglandin E2 production by human synovial cells. , 1986, The Journal of clinical investigation.

[33]  R. Russell,et al.  An interleukin 1 like factor stimulates bone resorption in vitro , 1983, Nature.

[34]  P. Lipsky,et al.  The role of interleukin 1 in human B cell activation: inhibition of B cell proliferation and the generation of immunoglobulin-secreting cells by an antibody against human leukocytic pyrogen. , 1983, Journal of immunology.

[35]  C. Dinarello,et al.  Molecular basis of fever in humans. , 1982, The American journal of medicine.

[36]  J. Caulfield,et al.  Morphologic demonstration of two stages in the development of type II collagen-induced arthritis. , 1982, Laboratory investigation; a journal of technical methods and pathology.

[37]  S. Krane,et al.  Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin 1). , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[38]  K. Paigen,et al.  A simple, rapid, and sensitive DNA assay procedure. , 1980, Analytical biochemistry.

[39]  W. Rutter,et al.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.

[40]  C. Dinarello,et al.  Adherent cell function in murine T-lymphocyte antigen recognition. IV. Enhancement of murine T-cell antigen recognition by human leukocytic pyrogen , 1978, The Journal of experimental medicine.

[41]  L. Rosenwasser,et al.  Adherent cell function in murine T lymphocyte antigen recognition. II. Definition of genetically restricted and nonrestricted macrophage functions in T cell proliferation. , 1978, Journal of immunology.

[42]  M. Ziff,et al.  Electron microscopic studies of the cartilage-pannus junction in rheumatoid arthritis. , 1975, Arthritis and rheumatism.